Coughing, Choking, Wheezing, Itching, Sneezing: Understanding the Connection Between Atopic Diseases Through a Case-Based Panel of Expert Nurse Practitioners

Join leading experts Miguel Lanz, Lakshi Aldredge, Angela Bretton, and Hilary Ugras in an engaging case-based discussion that explores the interconnected nature of chronic underlying type 2 inflammation and its profound impact across multiple diseases.

MD, FAAAAI

Miguel Lanz +3 more

On demand materials

Type 2 Inflammation

45 min

videoanimation

AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners

Learning objectives

Recognize common clinical signs and symptoms of type 2 inflammatory diseases commonly seen in primary care and determine when to refer to a specialist
Understand the underlying pathophysiology of type 2 inflammation in multiple atopic diseases
Explore the impact of multimorbidity on patient burden and apply collaborative strategies to optimize care

About these experts

Allergy/Immunology

MD, FAAAAI

Miguel Lanz

Lanz Allergy, Asthma & Immunology AAADRS Clinical Research Center | Coral Gables, FL

Dermatology

ANP-BC, DCNP, FAANP, MSN

Lakshi Aldredge

Director for the Primary Care NP Residency Program, VA Portland Health System | Portland, OR

Allergy/Immunology

APRN, FNP-BC, MSN

Angela Bretton

San Diego Allergy and Immunology | Vista, CA

Gastroenterology

FNP-BC, MSN

Hilary Ugras

Beth Israel Deaconess Medical Center | Boston, MA

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region